AIM
BSX icon

AXA Investment Managers’s Boston Scientific BSX Stock Holding History

AXA Investment Managers’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$275M Buy
+2,816,813
New +$292M 0.74% 22

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AXA Investment Managers's BSX Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Boston Scientific (BSX) in Q3 2025: 2,816,813 shares worth $275M. The stake represents 0.74% of the portfolio and ranks #22 among its holdings.

1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • AXA Investment Managers held 2,816,813 shares of Boston Scientific worth $275M as of Q3 2025.
  • Boston Scientific was a new AXA Investment Managers position in Q3 2025.
  • Boston Scientific made up 0.74% of AXA Investment Managers's portfolio in Q3 2025, its #22 holding.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.